ABSTRACT
Pediatric psychopharmacology informs on how psychotropic medications can be used to treat children with behavioral and emotional disorders. The observation that amphetamine dramatically improved behavior in hyperkinetic children goes back almost 70 years (Bradley, 1937), that is more than 10 years before tranquilizers, lithium, or antidepressants were introduced into the adult pharmacopeia. Still, pediatric psychopharmacology can be considered a relatively new area of inquiry, which only recently has started testing systematically the effects of psychotropics in the developmental age.
